Tomonori Shodai, J. Suzuki, S. Kudo, S. Itoh, M. Terada, S. Fujita, H. Shimazu, T. Tsuji (2003)
Inhibition of P-selectin-mediated cell adhesion by a sulfated derivative of sialic acid.Biochemical and biophysical research communications, 312 3
Y. Matsuura, H. Tani, Kensuke Suzuki, T. Kimura-Someya, R. Suzuki, H. Aizaki, K. Ishii, K. Moriishi, C. Robison, M. Whitt, T. Miyamura (2001)
Characterization of pseudotype VSV possessing HCV envelope proteins.Virology, 286 2
A. Beeck, J. Dubuisson (2003)
Topology of hepatitis C virus envelope glycoproteinsReviews in Medical Virology, 13
H. Barth, C. Schäfer, M. Adah, Fuming Zhang, R. Linhardt, H. Toyoda, A. Kinoshita-Toyoda, T. Toida, T. Kuppevelt, E. Depla, F. Weizsäcker, H. Blum, T. Baumert (2003)
Cellular Binding of Hepatitis C Virus Envelope Glycoprotein E2 Requires Cell Surface Heparan Sulfate*Journal of Biological Chemistry, 278
R. Clayton, A. Owsianka, J. Aitken, S. Graham, D. Bhella, A. Patel (2002)
Analysis of Antigenicity and Topology of E2 Glycoprotein Present on Recombinant Hepatitis C Virus-Like ParticlesJournal of Virology, 76
M. Alter, D. Kruszon-Moran, O. Nainan, G. Mcquillan, Fengxiang Gao, L. Moyer, Richard Kaslow, H. Margolis (1999)
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.The New England journal of medicine, 341 8
Hsin-Chieh Ma, Cheng-Hung Ke, Tsai‐Yuan Hsieh, S. Lo (2002)
The first hydrophobic domain of the hepatitis C virus E1 protein is important for interaction with the capsid protein.The Journal of general virology, 83 Pt 12
S. Takikawa, K. Ishii, H. Aizaki, Tetsuro Suzuki, H. Asakura, Y. Matsuura, T. Miyamura (2000)
Cell Fusion Activity of Hepatitis C Virus Envelope ProteinsJournal of Virology, 74
L. Cocquerel, J. Meunier, A. Pillez, C. Wychowski, J. Dubuisson (1998)
A Retention Signal Necessary and Sufficient for Endoplasmic Reticulum Localization Maps to the Transmembrane Domain of Hepatitis C Virus Glycoprotein E2Journal of Virology, 72
Amy WEINERt, H. Geysen, Cindy CHRISTOPHERSONt, J. HALLt, T. Mason, Giorgio, Saraccoi, F. Bonino, Kevin CRAWFORDt, D. Christopher, MARIONt, Kenneth CRAWFORDt, Maurizia, Brunetto, Philip BARRt, T. Miyamura, John MCHUTCHINSONtt, Michael HOUGHTONtt (1992)
Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections.Proceedings of the National Academy of Sciences of the United States of America, 89
R. Doms, R Lamb, J. Rose, A. Helenius (1993)
Folding and assembly of viral membrane proteins.Virology, 193 2
P. Bonis (1999)
Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin.The New England journal of medicine, 341 10
D. Shukla, P. Spear (2001)
Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry.The Journal of clinical investigation, 108 4
E. Murphy, S. Bryzman, Williams Ae (1999)
Prevalence of hepatitis C virus infection in the United States.The New England journal of medicine, 341 27
H. Kaneko, K. Kato, S. Mori, S. Shigeta (2001)
Antiviral activity of NMSO3 against adenovirus in vitro.Antiviral research, 52 3
K. Meyer, A. Basu, R. Ray (2000)
Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cells.Virology, 276 1
M. Hsu, Jie Zhang, M. Flint, C. Logvinoff, C. Cheng‐Mayer, C. Rice, J. McKeating (2003)
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particlesProceedings of the National Academy of Sciences of the United States of America, 100
Kazuo Takahashi, K. Ohashi, Yurika Abe, S. Mori, K. Taniguchi, T. Ebina, O. Nakagomi, M. Terada, S. Shigeta (2002)
Protective Efficacy of a Sulfated Sialyl Lipid (NMSO3) against Human Rotavirus-Induced Diarrhea in a Mouse ModelAntimicrobial Agents and Chemotherapy, 46
H. Drummer, A. Maerz, P. Poumbourios (2003)
Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteinsFEBS Letters, 546
E. Kenny‐Walsh (1999)
Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group.The New England journal of medicine, 340 16
H. Alter, R. Purcell, J. Shih, J. Melpolder, M. Houghton, Q. Choo, G. Kuo (1989)
Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.The New England journal of medicine, 321 22
A. Beeck, C. Voisset, B. Bartosch, Y. Ciczora, L. Cocquerel, Z. Keck, S. Foung, F. Cosset, J. Dubuisson (2004)
Characterization of Functional Hepatitis C Virus Envelope GlycoproteinsJournal of Virology, 78
L. Lagging, K. Meyer, R. Owens, R. Ray (1998)
Functional Role of Hepatitis C Virus Chimeric Glycoproteins in the Infectivity of Pseudotyped VirusJournal of Virology, 72
Aster Beyene, A. Basu, K. Meyer, R. Ray (2004)
Influence of N-linked glycans on intracellular transport of hepatitis C virus E1 chimeric glycoprotein and its role in pseudotype virus infectivity.Virology, 324 2
R. Garry, S. Dash (2003)
Proteomics computational analyses suggest that hepatitis C virus E1 and pestivirus E2 envelope glycoproteins are truncated class II fusion proteins.Virology, 307 2
L. Bruett, J. Clements (2001)
Functional Murine Leukemia Virus Vectors Pseudotyped with the Visna Virus Envelope Show Expanded Visna Virus Cell TropismJournal of Virology, 75
M. Hijikata, N. Kato, Y. Ootsuyama, M. Nakagawa, K. Shimotohno (1991)
Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis.Proceedings of the National Academy of Sciences of the United States of America, 88
A. Beeck, L. Cocquerel, J. Dubuisson (2001)
Biogenesis of hepatitis C virus envelope glycoproteins.The Journal of general virology, 82 Pt 11
L. Lagging, K. Meyer, J. Westin, R. Wejstål, G. Norkrans, M. Lindh, R. Ray (2002)
Neutralization of pseudotyped vesicular stomatitis virus expressing hepatitis C virus envelope glycoprotein 1 or 2 by serum from patients.The Journal of infectious diseases, 185 8
R. Germi, J. Crance, D. Garin, J. Guimet, H. Lortat‐Jacob, R. Ruigrok, J. Zarski, E. Drouet (2002)
Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorptionJournal of Medical Virology, 68
K. Kimura, S. Mori, K. Tomita, K. Ohno, Kazuo Takahashi, S. Shigeta, Masaki Terada (2000)
Antiviral activity of NMSO3 against respiratory syncytial virus infection in vitro and in vivo.Antiviral research, 47 1
Q. Choo, G. Kuo, A. Weiner, L. Overby, D. Bradley, M. Houghton (1989)
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.Science, 244 4902
K. Meyer, A. Basu, C. Przysiecki, L. Lagging, A. Bisceglie, A. Conley, R. Ray (2002)
Complement-Mediated Enhancement of Antibody Function for Neutralization of Pseudotype Virus Containing Hepatitis C Virus E2 Chimeric GlycoproteinJournal of Virology, 76
P. Pileri, Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi, R. Petracca, A. Weiner, M. Houghton, D. Rosa, G. Grandi, S. Abrignani (1998)
Binding of hepatitis C virus to CD81.Science, 282 5390
L. Cocquerel, C. Kuo, J. Dubuisson, S. Levy (2003)
CD81-Dependent Binding of Hepatitis C Virus E1E2 HeterodimersJournal of Virology, 77
B. Bartosch, J. Bukh, J. Meunier, Christelle Granier, R. Engle, W. Blackwelder, S. Emerson, F. Cosset, R. Purcell (2003)
In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopesProceedings of the National Academy of Sciences of the United States of America, 100
M. Yi, Y. Nakamoto, S. Kaneko, T. Yamashita, S. Murakami (1997)
Delineation of regions important for heteromeric association of hepatitis C virus E1 and E2.Virology, 231 1
Q. Choo, K. Richman, Jang Han, K. Berger, C. Lee, Christine Dong, C. Gallegos, D. Coit, R. Medina-Selby, P. Barr (1991)
Genetic organization and diversity of the hepatitis C virus.Proceedings of the National Academy of Sciences of the United States of America, 88
A. Ciccaglione, A. Costantino, C. Marcantonio, M. Equestre, A. Geraci, M. Rapicetta (2001)
Mutagenesis of hepatitis C virus E1 protein affects its membrane-permeabilizing activity.The Journal of general virology, 82 Pt 9
Michael Brown, J. Herz, J. Goldstein (1997)
LDL-receptor structure: Calcium cages, acid baths and recycling receptorsNature, 388
A. Grakoui, C. Wychowski, Chih-Ping Lin, S. Feinstone, C. Rice (1993)
Expression and identification of hepatitis C virus polyprotein cleavage productsJournal of Virology, 67
H. Kaneko, S. Mori, S. Shigeta, S. Ohno, K. Aoki (2003)
[Antiviral effect of sulfated sialyl lipid against a clinical strain of adenovirus].Nippon Ganka Gakkai zasshi, 107 4
M. Monazahian, I. Böhme, S. Bonk, Andrea Koch, C. Scholz, S. Grethe, R. Thomssen (1999)
Low density lipoprotein receptor as a candidate receptor for hepatitis C virusJournal of Medical Virology, 57
T. Baumert, Susumu Ito, David Wong, T. Liang (1998)
Hepatitis C Virus Structural Proteins Assemble into Viruslike Particles in Insect CellsJournal of Virology, 72
A. Basu, Aster Beyene, K. Meyer, R. Ray (2004)
The Hypervariable Region 1 of the E2 Glycoprotein of Hepatitis C Virus Binds to Glycosaminoglycans, but This Binding Does Not Lead to Infection in a Pseudotype SystemJournal of Virology, 78
L. Cocquerel, S. Duvet, J. Meunier, A. Pillez, R. Cacan, C. Wychowski, J. Dubuisson (1999)
The Transmembrane Domain of Hepatitis C Virus Glycoprotein E1 Is a Signal for Static Retention in the Endoplasmic ReticulumJournal of Virology, 73
Lo Shih-Yen, M. Selby, OU JING-HSIUNG (1996)
Interaction between hepatitis C virus core protein and E1 envelope proteinJournal of Virology, 70
J. Patel, A. Patel, J. McLauchlan (2001)
The transmembrane domain of the hepatitis C virus E2 glycoprotein is required for correct folding of the E1 glycoprotein and native complex formation.Virology, 279 1
B. Bartosch, J. Dubuisson, F. Cosset (2003)
Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein ComplexesThe Journal of Experimental Medicine, 197
Jie Zhang, G. Randall, A. Higginbottom, P. Monk, C. Rice, J. McKeating (2004)
CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral InfectionJournal of Virology, 78
M. Flint, C. Maidens, L. Loomis-Price, C. Shotton, J. Dubuisson, P. Monk, A. Higginbottom, S. Levy, J. McKeating (1999)
Characterization of Hepatitis C Virus E2 Glycoprotein Interaction with a Putative Cellular Receptor, CD81Journal of Virology, 73
A. Takamizawa, C. Mori, I. Fuke, S. Manabe, S. Murakami, J. Fujita, E. Onishi, T. Andoh, I. Yoshida, Hiroto Okayama (1991)
Structure and organization of the hepatitis C virus genome isolated from human carriersJournal of Virology, 65
V. Agnello, G. Abel, Mutasim Elfahal, G. Knight, Qing-Xiu Zhang (1999)
Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor.Proceedings of the National Academy of Sciences of the United States of America, 96 22
J. Hassell, J. Kimura, V. Hascall (1986)
Proteoglycan core protein families.Annual review of biochemistry, 55
Journal of Virology – Unpaywall
Published: Nov 12, 2004
Access the full text.
Sign up today, get DeepDyve free for 14 days.